Skip to content

Role of homoeopathic medicines in tinea corporis

Role of individualized homoeopathic medicine in the treatment of tinea corporis using fifty millesimal scale: An open-label clinical study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097483
Enrollment
40
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Individualized homoeopathic medicine in fifty millesimal potency.: All patients will be prescribed individualized homoeopathic medicine after detailed case taking in accordance with the

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of tinea corporis (ICD-10-B35.4) confirmed by KOH mount test. 2. Age group between 18 to 60 years. 3. All genders. 4. Participants who are willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated with other skin conditions-psoriasis, eczema, seborrheic dermatitis, pityriasis rosea, impetigo, lichen planus, discoid lupus erythematous, and drug induced skin lesions. 2. Currently receiving homoeopathic treatment for chronic condition(s). 3. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life. 4. Participants diagnosed with diabetes mellitus. 5. mmune-compromised patients.

Design outcomes

Primary

MeasureTime frame
Clinical Assessment Severity Score (CASS) used to assess and track the severity of tinea corporis infection.Timepoint: Assessment of scores at baseline, after 3 months and 6 months of treatment .

Secondary

MeasureTime frame
Visual Analogue Scale (VAS) used to assess the severity of pruritus.Timepoint: Assessment of scores at baseline, after 3 months and 6 months of treatment .

Countries

India

Contacts

Public ContactProf Dr Indrani Chakrabarti

National Institute of Homoeopathy kolkata

indrani.abc@gmail.com9433902555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026